Jonas Müntze

456 total citations
15 papers, 231 citations indexed

About

Jonas Müntze is a scholar working on Physiology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jonas Müntze has authored 15 papers receiving a total of 231 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 7 papers in Epidemiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jonas Müntze's work include Lysosomal Storage Disorders Research (11 papers), Trypanosoma species research and implications (6 papers) and Cardiac Structural Anomalies and Repair (3 papers). Jonas Müntze is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Trypanosoma species research and implications (6 papers) and Cardiac Structural Anomalies and Repair (3 papers). Jonas Müntze collaborates with scholars based in Germany and Norway. Jonas Müntze's co-authors include Peter Nordbeck, Christoph Wanner, Daniel Oder, Kai Hu, Dan Liu, Daniel Gensler, Stefan Frantz, Tim Salinger, Kristina Lorenz and Octavian Maniuc and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and European Heart Journal.

In The Last Decade

Jonas Müntze

14 papers receiving 223 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonas Müntze Germany 10 191 94 77 63 46 15 231
Eduardo Payá Spain 6 165 0.9× 128 1.4× 50 0.6× 38 0.6× 48 1.0× 13 297
Hui-Ying Yeh Taiwan 4 295 1.5× 133 1.4× 83 1.1× 93 1.5× 82 1.8× 6 326
Sudheera Magage Czechia 8 260 1.4× 149 1.6× 95 1.2× 67 1.1× 68 1.5× 16 318
Michelina Sibilio Italy 11 86 0.5× 35 0.4× 21 0.3× 29 0.5× 88 1.9× 19 253
Sabrina Nordin United Kingdom 4 199 1.0× 129 1.4× 63 0.8× 20 0.3× 35 0.8× 6 283
Jan C. van der Meijden Netherlands 10 239 1.3× 49 0.5× 24 0.3× 47 0.7× 156 3.4× 14 279
Khan Nedd United States 5 138 0.7× 69 0.7× 28 0.4× 50 0.8× 43 0.9× 6 150
Angelica Rampazzo Italy 10 209 1.1× 119 1.3× 33 0.4× 27 0.4× 78 1.7× 14 241
Serge Rivera France 5 74 0.4× 35 0.4× 24 0.3× 22 0.3× 27 0.6× 6 127
Hiroyuki Teraguchi Japan 5 445 2.3× 333 3.5× 137 1.8× 83 1.3× 133 2.9× 6 578

Countries citing papers authored by Jonas Müntze

Since Specialization
Citations

This map shows the geographic impact of Jonas Müntze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Müntze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Müntze more than expected).

Fields of papers citing papers by Jonas Müntze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Müntze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Müntze. The network helps show where Jonas Müntze may publish in the future.

Co-authorship network of co-authors of Jonas Müntze

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Müntze. A scholar is included among the top collaborators of Jonas Müntze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Müntze. Jonas Müntze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Müntze, Jonas, et al.. (2023). Contrast-enhanced ultrasound for non-invasive differential diagnosis of unclear left atrial mass. The International Journal of Cardiovascular Imaging. 39(11). 2173–2174.
2.
Müntze, Jonas, Markus Cybulla, Eva Brand, et al.. (2022). Patient reported quality of life and medication adherence in Fabry disease patients treated with migalastat: A prospective, multicenter study. Molecular Genetics and Metabolism. 138(2). 106981–106981. 15 indexed citations
3.
Oder, Daniel, Jonas Müntze, & Peter Nordbeck. (2021). Contemporary therapeutics and new drug developments for treatment of Fabry disease: a narrative review. Cardiovascular Diagnosis and Therapy. 11(2). 683–695. 5 indexed citations
4.
Gensler, Daniel, Jonas Müntze, & Peter Nordbeck. (2019). Long‐term outcome after surgical repair of a rapid‐grown ischemic ventricular aneurysm causing ventricular tachycardia. SHILAP Revista de lepidopterología. 7(3). 413–415. 2 indexed citations
5.
Maniuc, Octavian, Tim Salinger, Jonas Müntze, et al.. (2019). Impella CP Use in Patients with Non-Ischaemic Cardiogenic Shock. ESC Heart Failure. 6(4). 863–866. 10 indexed citations
6.
Liu, Dan, Kai Hu, Jonas Müntze, et al.. (2018). Value of the CHA2DS2-VASc score and Fabry-specific score for predicting new-onset or recurrent stroke/TIA in Fabry disease patients without atrial fibrillation. Clinical Research in Cardiology. 107(12). 1111–1121. 12 indexed citations
7.
Shehata-Dieler, Wafaa, Mario Cebulla, Daniel Oder, et al.. (2018). Characterization of vertigo and hearing loss in patients with Fabry disease. Orphanet Journal of Rare Diseases. 13(1). 137–137. 17 indexed citations
8.
Oder, Daniel, Dan Liu, Nurcan Üçeyler, et al.. (2018). Clinical impact of the alpha-galactosidase A gene single nucleotide polymorphism -10C>T. Medicine. 97(21). e10669–e10669. 3 indexed citations
9.
Salinger, Tim, Kai Hu, Dan Liu, et al.. (2018). Association between Comorbidities and Progression of Transvalvular Pressure Gradients in Patients with Moderate and Severe Aortic Valve Stenosis. Cardiology Research and Practice. 2018. 1–7. 3 indexed citations
10.
Müntze, Jonas, Daniel Gensler, Octavian Maniuc, et al.. (2018). Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year. Clinical Pharmacology & Therapeutics. 105(5). 1224–1233. 69 indexed citations
11.
Müntze, Jonas, Tim Salinger, Daniel Gensler, Christoph Wanner, & Peter Nordbeck. (2018). Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy. European Heart Journal. 39(20). 1861–1862. 12 indexed citations
12.
Liu, Dan, Daniel Oder, Tim Salinger, et al.. (2018). Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease. Open Heart. 5(2). e000803–e000803. 23 indexed citations
13.
Müntze, Jonas, et al.. (2018). Hot topics in Fabry disease. Postgraduate Medical Journal. 94(1118). 709–713. 23 indexed citations
14.
Shehata-Dieler, Wafaa, Mario Cebulla, Kris ten Rak, et al.. (2017). Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease. PLoS ONE. 12(11). e0188103–e0188103. 10 indexed citations
15.
Oder, Daniel, Dan Liu, Kai Hu, et al.. (2017). α-Galactosidase A Genotype N215S Induces a Specific Cardiac Variant of Fabry Disease. Circulation Cardiovascular Genetics. 10(5). 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026